Fri, Dec 22, 2023
Pharma shares gave returns ranging from 15% to 90%... Nifty Pharma reached record level. Nifty Pharma: What are the triggers of the rise? See here...
More >
Mon, Dec 11, 2023
Reddy's Laboratories Ltd (DRREDDY) shares plunged after the drug maker received three observations from the US drug maker for its Bachupally facility in Hyderabad.
Fri, Oct 27, 2023
Dr Reddy's reported a better-than-expected 33 per cent jump in consolidated net profit to Rs 1,480 crore for the July-September period.
Fri, Sep 29, 2023
Aurobindo Pharma surged on Friday, trading in huge volumes, after sources told Zee Business that the company received approval to launch its Revlimid drug.
Thu, Sep 21, 2023
Cipla shares remained under pressure on Thursday after the US drug regulator issued five observations about a New York-based facility of the company's wholly-owned subsidiary, InvaGen Pharmaceuticals.
Fri, Aug 11, 2023
Aurobindo Pharma is likely to report a 12.7 per cent year-on-year jump in consolidated net profit to Rs 586 crore for the quarter ended June 30, according to Zee Business research.
Divi's Labs is likely to report a 42.6 per cent year-on-year fall in consolidated net profit to Rs 403 crore for the quarter ended June 30, according to Zee Business research.
Fri, Jul 28, 2023
Dr Reddy's Laboratories (DRL) shares have scaled a series of record peaks in the past few days. This week, the pharmaceutical major reported a strong all-round quarterly performance, with a better-than-expected 18.2 per cent year-on-year increase in net profit to Rs 1,405 crore for the April-June period.
Tue, Jul 25, 2023
Dr Reddy's Labs is scheduled to report its financial results for the June quarter on July 26. Analysts expect DRLto stage a strong quarterly performance driven by growing demand and improving margin.
Thu, Jul 20, 2023
Dr Reddy's Labs shares scaled a 52-week high on Thursday after the drug maker said the US regulator completed an inspection at its Srikakulam API facility without any observation.
Wed, May 31, 2023
Torrent Pharma shares surged to a 52-week high on Wednesday, a day after the drug maker reported a quarterly net profit as against a net loss for the corresponding period a year ago.
Fri, May 19, 2023
Gland Pharma share price NSE, Gland Pharma share price target: Gland Pharma shares plunged on Friday 20, a day after the Hyderabad-based generic injectable manufacturer reported a weak set of financial results for the quarter ended March 2023.
Tue, May 16, 2023
Granules India Q4 results, dividend news: Granules India — a Hyderabad-based pharma company that makes Paracetamol and Ibuprofen — reported a net profit of Rs 119.6 crore for the quarter ended March 2023, missing analysts' estimates. Granules India's board recommended a dividend of 150 per cent.
Mon, May 15, 2023
Granules India Q4 results preview: Granules India, which manufactures painkiller drug Paracetamol and anti-inflammatory drug Ibuprofen, will report its Q4 results on May 16. Will Granules India also announce a dividend?
Tue, Mar 14, 2023
Lupin, Sun Pharma share price: Wild swings in the Indian share market come in the backdrop of sharp falls in the global markets owing to weakness in the banking space, after the collapse of US-based startup lender Silicon Valley Bank following a failed attempt to raise capital.
Tue, Feb 28, 2023
Nifty Pharma and BSE Healthcare indices were trading below the flat line as most drug makers like Cipla, Biocon, Dr Reddy’s, and Alkem among others were a mixed bag
Wed, Dec 14, 2022
The volatility seen in 2022 is likely to carry forward till the first half of the next year, WhiteOak Capital, Chief Executive Officer, Aashish P Sommaiyaa said while speaking to Zee Business.
Wed, Nov 09, 2022
Divi’s Laboratories stock has corrected from highs of Rs 3,829.10, it hit on 1 November, witnessing a fall of Rs 545 or 17%
Fri, Oct 28, 2022
Technical analyst Nilesh Jain suggests an avoid in this scrip citing that the stock has moved significantly in last few trading sessions
Mon, Oct 03, 2022
In contrast to the benchmark indices, the pharma and healthcare indices surged in a weak market.
Thu, Sep 29, 2022
The Nifty Pharma is one of the top sectoral gainers as compared to a 0.16% fall in the Nifty, it jumped by 3.5% this week against to 1.5% fall in the benchmark index.
Sat, Apr 02, 2022
The broader markets have outperformed the benchmarks during April Series, as Nifty Midcap grew by 5.4 per cent and small-cap 6 per cent on an average of 5 years, the report noted.
Mon, Dec 27, 2021
Leading the maximum surge in the markets, the pharma stocks from across segment are on the roll a day after Prime Minister Narendra Modi on Saturday announced precautionary shorts in the wake of Omicron, a new Covid variant, spread in the country.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
